{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:15Z","timestamp":1791994575859,"version":"4.4.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2222,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1111\/j.1365-2133.2009.09208.x","type":"journal-article","created":{"date-parts":[[2009,4,11]],"date-time":"2009-04-11T03:43:53Z","timestamp":1239421433000},"page":"313-319","source":"Crossref","is-referenced-by-count":38,"title":["The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study"],"prefix":"10.1093","volume":"161","author":[{"given":"M.","family":"El-Darouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Abdel Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"El Tawdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Leheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gammaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Al Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI110615","article-title":"Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes","volume":"70","author":"Stanley","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1747.1998.00086.x","article-title":"Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals","volume":"110","author":"Hertl","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2133.2005.06744.x","article-title":"Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab","volume":"153","author":"Jacobi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB5","first-page":"245","article-title":"Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept","volume":"74","author":"Berookhim","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2567.2001.01272.x","article-title":"Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression","volume":"103","author":"Hask\u00f3","year":"2001","journal-title":"Immunology"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4049\/jimmunol.156.1.218","article-title":"Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells","volume":"156","author":"Bissonnette","year":"1996","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2567.1997.00246.x","article-title":"Inhibition of human interleukin-12 production by pentoxifylline","volume":"91","author":"Moller","year":"1997","journal-title":"Immunology"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2005.06672.x","article-title":"Infliximab in the management of severe pemphigus vulgaris","volume":"153","author":"Pardo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/eji.1830230802","article-title":"Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats","volume":"23","author":"Rott","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","article-title":"Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes","volume":"90","author":"Neuner","year":"1997","journal-title":"Immunology"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0378-6323.41366","article-title":"Current regimen of pulse therapy for pemphigus: minor modifications, improved results","volume":"743","author":"Pasricha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2009.09208.x-BIB13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies","volume":"10","author":"Brattsand","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/08916930600972040","article-title":"Immunoadsorption in pemphigus","volume":"39","author":"Eming","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2133.2007.08416.x","article-title":"Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay","volume":"158","author":"Nagasaka","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature","volume":"143","author":"Cianchini","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaad.2008.01.007","article-title":"Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus","volume":"58","author":"Czernik","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB19","first-page":"427","article-title":"Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells","volume":"50","author":"Niedbala","year":"1991","journal-title":"Biomed Biochim Acta"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1523-1747.ep12285633","article-title":"C3 production of cultured human epidermal keratinocytes is enhanced by IFNgamma and TNFalpha through different pathways","volume":"108","author":"Terui","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1034\/j.1600-0625.2002.120415.x","article-title":"Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis","volume":"12","author":"Feliciani","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB23","first-page":"383","article-title":"Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity","volume":"8","author":"D\u2019Auria","year":"1997","journal-title":"Eur Cytokine Netw"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB24","first-page":"121","article-title":"ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients","volume":"58","author":"Alecu","year":"1999","journal-title":"Roum Arch Microbiol Immunol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0049-0172(96)80035-7","article-title":"Effects of antirheumatic agents on cytokines","volume":"25","author":"Barrera","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CDLI.2.6.689-692.1995","article-title":"Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta IL-1 beta, and IL-10 by human leukocytes","volume":"2","author":"van Furth","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jlb.40.6.747","article-title":"Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells","volume":"40","author":"Bessler","year":"1986","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archderm.141.6.680","article-title":"Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser","volume":"141","author":"Lin","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2474-9-52","article-title":"Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety","volume":"9","author":"Alonso-Ruiz","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2036.2002.01156.x","article-title":"Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn\u2019s disease","volume":"16","author":"Dewit","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2133.2009.09208.x-BIB31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bcp.2007.05.013","article-title":"A novel drug interaction between the quinolone antibiotic ciprofloxacin and a chiral metabolite of pentoxifylline","volume":"74","author":"Raoul","year":"2007","journal-title":"Biochem Pharmacol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09208.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:22:04Z","timestamp":1710256924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/2\/313\/6642567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09208.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}